Caplin Point Laboratories Ltd has informed BSE that in connection with the approval of the Companys state of art sterile injectable facility (Unit IV) under European GMP, the Officials of EU GMP had carried out inspection of the unit recently. The outcome of the inspection is very positive and it is likely that the approval may be accorded shortly. The Company shall update upon receipt of the final communication from the said Authorities.

Source : BSE - www.bseindia.com

Published on March 24, 2015


This article is closed for comments.
Please Email the Editor